Megan Dover

Junior Partner & Co-Founder | Cross Border Impact Ventures

Megan Dover, Co-founder & Junior Partner of Cross Border Impact Ventures (CBIV), has in depth experience in impact investing, angel investing, venture advisory, M&A, business strategy and Financial Planning & Analysis. At CBIV, she invests in Series A stage distruptive health technology companies in North America and Europe that address unmet needs for women and children globally. Megan has also held senior level roles in corporate finance and strategy for a publicly traded mining and infrastructure company, worked in management consulting for a global consulting firm, worked in R&D for a cardiovascular medtech startup and acts as an advisor and angel investor at the Creative Destruction Lab (CDL) in Toronto. Megan obtained her MBA from the Rotman School of Management at the University of Toronto, receiving a Dean’s list ranking. She also earned her Engineering degree with Honours from Queen’s University, specializing in Biomedical Research within Chemical Engineering.